Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?

Publication

Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?

Journal Paper/Review - May 26, 2023

Wong Raymond, Hejrati Nader, Fehlings Michael G

Citation

Wong R, Hejrati N, Fehlings M. Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?. Expert Rev Neurother 2023; 23:487-499.

Type

Journal Paper/Review (English)

Journal

Expert Rev Neurother 2023; 23

Publication Date

May 26, 2023

Issn Electronic

1744-8360

Pages

487-499

Brief description/objective

There remains a lack of effective regenerative therapies to treat traumatic spinal cord injury (SCI). On a global level, patients living with SCI, their families, and the healthcare system are impacted by the extensive financial burden associated with the management of SCI. Clinical trials are crucial to assess the real-world efficacy of the different emerging neuroregenerative approaches that have shown promise in the pre-clinical stages of research.